SC
FTXH icon

Steph & Co’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Steph & Co’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,990
Closed -$142K – 318
2025
Q3 		$142K Buy
+4,990
New +$136K 0.04% 126

Other funds holding FTXH

LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
MIM
Marshall Investment Management Littleton, Colorado $241M AUM 30.53% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.75B AUM 46.53% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.31B AUM 20.77% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
VCM
Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return

Steph & Co's FTXH Position: Q4 2025 in Review

Steph & Co sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q4 2025, closing a stake of 4,990 shares — an estimated $142K sold.

Steph & Co first reported a position in FTXH in Q3 2025 and held it in 1 quarter. The position peaked at $142K in Q3 2025. 26 funds tracked by Wall St. Rank hold FTXH as of Q4 2025.

  • Steph & Co reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q4 2025 after selling out during the quarter.
  • Steph & Co sold 4,990 First Trust Nasdaq Pharmaceuticals ETF shares in Q4 2025, an estimated $142K.
  • Steph & Co first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q3 2025 and held it in 1 quarter.
  • Steph & Co's First Trust Nasdaq Pharmaceuticals ETF position peaked at $142K in Q3 2025.
  • 26 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q4 2025.

Based on Steph & Co's 13F filing for Q4 2025, filed 23 Jan 2026.